TY - JOUR AU - Stupp, R. AU - Mason, W. P. AU - van den Bent, M. J. AU - Weller, M. AU - Fisher, B. AU - Taphoorn, M. J. PY - 2005 DA - 2005// TI - Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043330 DO - 10.1056/NEJMoa043330 ID - Stupp2005 ER - TY - JOUR AU - Tosoni, A. AU - Franceschi, E. AU - Poggi, R. AU - Brandes, A. A. PY - 2016 DA - 2016// TI - Relapsed glioblastoma: treatment strategies for initial and subsequent recurrences JO - Curr Treat Options in Oncol VL - 17 UR - https://doi.org/10.1007/s11864-016-0422-4 DO - 10.1007/s11864-016-0422-4 ID - Tosoni2016 ER - TY - JOUR AU - Batash, R. AU - Asna, N. AU - Schaffer, P. AU - Francis, N. AU - Schaffer, M. PY - 2017 DA - 2017// TI - Glioblastoma Multiforme, Diagnosis and treatment; Recent Literature Review JO - Curr Med Chem VL - 24 ID - Batash2017 ER - TY - JOUR PY - 2008 DA - 2008// TI - Comprehensive genomic characterization defines human glioblastoma genes and core pathways JO - Nature VL - 455 UR - https://doi.org/10.1038/nature07385 DO - 10.1038/nature07385 ID - ref4 ER - TY - STD TI - Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. The Somatic Genomic Landscape of Glioblastoma. Cell. 2013; October 10. ID - ref5 ER - TY - JOUR AU - Humphrey, P. A. AU - Wong, A. J. AU - Vogelstein, B. AU - Zalutsky, M. R. AU - Fuller, G. N. AU - Archer, G. E. PY - 1990 DA - 1990// TI - Anti-synthetic peptide antibody reacting at the fusion junction of deletion mutant epidermal growth factor receptors in human glioblastoma JO - Proc Natl Acad Sci U S A VL - 87 UR - https://doi.org/10.1073/pnas.87.11.4207 DO - 10.1073/pnas.87.11.4207 ID - Humphrey1990 ER - TY - JOUR AU - Zonta, E. AU - Garlan, F. AU - Pécuchet, N. AU - Perez-Toralla, K. AU - Caen, O. AU - Milbury, C. PY - 2016 DA - 2016// TI - Multiplex detection of rare mutations by Picoliter droplet based digital PCR: sensitivity and specificity considerations JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0159094 DO - 10.1371/journal.pone.0159094 ID - Zonta2016 ER - TY - JOUR AU - Donnadieu, J. AU - Lachaier, E. AU - Peria, M. AU - Saidak, Z. AU - Dakpe, S. AU - Ikoli, J. F. AU - Chauffert, B. AU - Page, C. AU - Galmiche, A. PY - 2016 DA - 2016// TI - Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2318-x DO - 10.1186/s12885-016-2318-x ID - Donnadieu2016 ER - TY - CHAP AU - Louis, D. N. AU - Ohgaki, H. AU - Wiestler, O. D. AU - Cavenee, W. K. W. H. O. PY - 2016 DA - 2016// TI - Classification of Tumours of the central nervous system. WHO classification of Tumours, revised 4th edition, volume 1 BT - IARC press ID - Louis2016 ER - TY - JOUR AU - Wen, P. Y. AU - Macdonald, D. R. AU - Reardon, D. A. PY - 2010 DA - 2010// TI - Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.3541 DO - 10.1200/JCO.2009.26.3541 ID - Wen2010 ER - TY - JOUR AU - Yang, J. C. AU - Sequist, L. V. AU - Geater, S. L. AU - Tsai, C. M. AU - Mok, T. S. AU - Schuler, M. PY - 2015 DA - 2015// TI - Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00026-1 DO - 10.1016/S1470-2045(15)00026-1 ID - Yang2015 ER - TY - JOUR AU - Shen, Y. C. AU - Tseng, G. C. AU - Tu, C. Y. AU - Chen, W. C. AU - Liao, W. C. AU - Chen, W. C. AU - Li, C. H. AU - Chen, H. J. AU - Hsia, T. C. PY - 2017 DA - 2017// TI - Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lungadenocarcinoma harboring non-classical epidermal growth factor receptor mutations JO - Lung Cancer VL - 110 UR - https://doi.org/10.1016/j.lungcan.2017.06.007 DO - 10.1016/j.lungcan.2017.06.007 ID - Shen2017 ER - TY - JOUR AU - Kobayashi, Y. AU - Mitsudomi, T. PY - 2016 DA - 2016// TI - Not all epidermal growth factor receptor mutations in lung cancer are created equal: perspectives for individualized treatment strategy JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12996 DO - 10.1111/cas.12996 ID - Kobayashi2016 ER - TY - JOUR AU - Douillard, J. Y. AU - Ostoros, G. AU - Cobo, M. PY - 2014 DA - 2014// TI - First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2013.721 DO - 10.1038/bjc.2013.721 ID - Douillard2014 ER - TY - JOUR AU - Lynch, T. h. o. m. a. s. J. AU - Bell, D. a. p. h. n. e. W. AU - Sordella, R. a. f. f. a. e. l. l. a. AU - Gurubhagavatula, S. a. r. a. d. a. AU - Okimoto, R. o. s. s. A. AU - Brannigan, B. r. i. a. n. W. AU - Harris, P. a. t. r. i. c. i. a. L. AU - Haserlat, S. a. r. a. M. AU - Supko, J. e. f. f. r. e. y. G. AU - Haluska, F. r. a. n. k. G. AU - Louis, D. a. v. i. d. N. AU - Christiani, D. a. v. i. d. C. AU - Settleman, J. e. f. f. AU - Haber, D. a. n. i. e. l. A. PY - 2004 DA - 2004// TI - Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib JO - New England Journal of Medicine VL - 350 UR - https://doi.org/10.1056/NEJMoa040938 DO - 10.1056/NEJMoa040938 ID - Lynch2004 ER - TY - JOUR AU - Kohno, T. AU - Nakaoku, T. AU - Tsuta, K. AU - Tsuchihara, K. AU - Matsumoto, S. AU - Yoh, K. AU - Beyond, G. K. PY - 2015 DA - 2015// TI - ALK-RET, ROS1 and other oncogene fusions in lung cancer JO - Transl Lung Cancer Res VL - 4 ID - Kohno2015 ER - TY - JOUR AU - Castellanos, E. AU - Feld, E. AU - Horn, L. PY - 2017 DA - 2017// TI - Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2016.12.014 DO - 10.1016/j.jtho.2016.12.014 ID - Castellanos2017 ER - TY - JOUR AU - Chiu, C. H. AU - Yang, C. T. AU - Shih, J. Y. AU - Huang, M. S. AU - Su, W. C. AU - Lai, R. S. AU - Wang, C. C. AU - Hsiao, S. H. AU - Lin, Y. C. AU - Ho, C. L. PY - 2015 DA - 2015// TI - Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X/L861Q/S768I mutations JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000504 DO - 10.1097/JTO.0000000000000504 ID - Chiu2015 ER - TY - JOUR AU - Reardon, D. A. AU - Nabors, L. B. AU - Mason, W. P. AU - Perry, J. R. AU - Shapiro, W. AU - Kavan, P. PY - 2015 DA - 2015// TI - BI 1200 36 Trial Group and the Canadian Brain Tumour Consortium Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma JO - Neuro Oncol VL - 17 ID - Reardon2015 ER - TY - JOUR AU - Abbott, N. J. AU - Patabendige, A. A. AU - Dolman, D. E. PY - 2010 DA - 2010// TI - Structure and function of the blood-brain barrier JO - Neurobiol Dis VL - 37 UR - https://doi.org/10.1016/j.nbd.2009.07.030 DO - 10.1016/j.nbd.2009.07.030 ID - Abbott2010 ER - TY - JOUR AU - Ostermann, S. AU - Csajka, C. AU - Buclin, T. PY - 2004 DA - 2004// TI - Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0807 DO - 10.1158/1078-0432.CCR-03-0807 ID - Ostermann2004 ER - TY - JOUR AU - Clarke, J. L. AU - Pao, W. AU - Wu, N. PY - 2010 DA - 2010// TI - High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer JO - J Neuro-Oncol VL - 99 UR - https://doi.org/10.1007/s11060-010-0128-6 DO - 10.1007/s11060-010-0128-6 ID - Clarke2010 ER - TY - JOUR AU - Deng, Y. AU - Feng, W. AU - Wu, J. PY - 2014 DA - 2014// TI - The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small cell lung cancer JO - Mol Clin Oncol VL - 2 UR - https://doi.org/10.3892/mco.2013.190 DO - 10.3892/mco.2013.190 ID - Deng2014 ER - TY - JOUR AU - Hoffknecht, P. AU - Tufman, A. AU - Wehler, T. PY - 2015 DA - 2015// TI - Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000380 DO - 10.1097/JTO.0000000000000380 ID - Hoffknecht2015 ER - TY - JOUR AU - Yang, J. C. AU - Hirsh, V. AU - Schuler, M. PY - 2013 DA - 2013// TI - Symptom control and quality of life in LUX-lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.1764 DO - 10.1200/JCO.2012.46.1764 ID - Yang2013 ER - TY - JOUR AU - Kopetz, S. AU - Desai, J. AU - Chan, E. AU - Hecht, J. R. AU - O’Dwyer, P. J. AU - Maru, D. AU - Morris, V. AU - Janku, F. AU - Dasari, A. AU - Chung, W. AU - Issa, J. P. AU - Gibbs, P. AU - James, B. AU - Powis, G. AU - Nolop, K. B. AU - Bhattacharya, S. AU - Saltz, L. PY - 2015 DA - 2015// TI - Phase II pilot study of Vemurafenib in patients with metastatic BRAF-mutated colorectal Cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.2497 DO - 10.1200/JCO.2015.63.2497 ID - Kopetz2015 ER - TY - STD TI - Diamond EL, Subbiah V, Lockhart AC, Blay JY, Puzanov I, Chau I, Raje NS, Wolf J, Erinjeri JP, Torrisi J, Lacouture M, Elez E, Martínez-Valle F, Durham B, Arcila ME, Ulaner G, Abdel-Wahab O, Pitcher B, Makrutzki M, Riehl T, Baselga J, Hyman DM. Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell Histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncol. 2017;4(3):384–88. ID - ref27 ER - TY - JOUR AU - Openshaw, M. R. AU - Page, K. AU - Fernandez-Garcia, D. AU - Guttery, D. AU - Shaw, J. A. PY - 2016 DA - 2016// TI - The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring JO - Expert Rev Mol Diagn VL - 16 UR - https://doi.org/10.1080/14737159.2016.1184974 DO - 10.1080/14737159.2016.1184974 ID - Openshaw2016 ER - TY - JOUR AU - Spindler, K. G. PY - 2017 DA - 2017// TI - Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer JO - Acta Oncol VL - 56 UR - https://doi.org/10.1080/0284186X.2016.1253861 DO - 10.1080/0284186X.2016.1253861 ID - Spindler2017 ER - TY - JOUR AU - Jiang, T. AU - Ren, S. AU - Zhou, C. PY - 2015 DA - 2015// TI - Role of circulating-tumor DNA analysis in non-small cell lung cancer JO - Lung Cancer VL - 90 UR - https://doi.org/10.1016/j.lungcan.2015.09.013 DO - 10.1016/j.lungcan.2015.09.013 ID - Jiang2015 ER - TY - JOUR AU - Bettegowda, C. AU - Sausen, M. AU - Leary, R. J. AU - Kinde, I. AU - Wang, Y. AU - Agrawal, N. PY - 2014 DA - 2014// TI - Detection of circulating tumor DNA in early- and late-stage human malignancies JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3007094 DO - 10.1126/scitranslmed.3007094 ID - Bettegowda2014 ER - TY - JOUR AU - Schwaederle, M. AU - Husain, H. AU - Fanta, P. T. AU - Piccioni, D. E. AU - Kesari, S. AU - Schwab, R. B. PY - 2016 DA - 2016// TI - Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7110 DO - 10.18632/oncotarget.7110 ID - Schwaederle2016 ER - TY - JOUR AU - De Mattos-Arruda, L. AU - Mayor, R. AU - Ng, C. K. AU - Weigelt, B. AU - Martínez-Ricarte, F. AU - Torrejon, D. AU - Oliveira, M. AU - Arias, A. AU - Raventos, C. AU - Tang, J. AU - Guerini-Rocco, E. PY - 2015 DA - 2015// TI - Cerebrospinal fluid-derived circulating tumour DNA JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms9839 DO - 10.1038/ncomms9839 ID - De Mattos-Arruda2015 ER - TY - STD TI - Juratli TA, Stasik S, Zolal A, Schuster C, Richter S, Daubner D, Juratli MA, Thowe RT, Hennig S, Makina M, Meinhardt M, Lautenschlaeger T, Schackert G, Krex D, Thiede C. TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas - a pilot prospective study. Clin Cancer Res. 2018. https://doi.org/10.1158/1078-0432.CCR-17-3717. ID - ref34 ER -